Flagship Pioneering Fund VII General Partner LLC's Net Worth

$0

Estimate Recalculated Nov 1, 2024 06:16AM EST

Who is Flagship Pioneering Fund VII General Partner LLC?

Flagship Pioneering Fund VII General Partner LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Evelo Biosciences, Inc., Seres Therapeutics, Inc., Omega Therapeutics, Inc., Sana Biotechnology, Inc., and Foghorn Therapeutics Inc..

SEC CIK

Flagship Pioneering Fund VII General Partner LLC's CIK is 0001805917

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Evelo Biosciences, Inc. (EVLO) Snapshot price: $0.0001

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+366.75%
5.41M
$2.31
$12,499,999.05
6.89M
Jul 11
Form 3
—
0
—
—
0
No matching records found

Seres Therapeutics, Inc. (MCRB) Snapshot price: $1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Omega Therapeutics, Inc. (OMGA) Snapshot price: $1.22

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Sana Biotechnology, Inc. (SANA) Snapshot price: $5.05

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Foghorn Therapeutics Inc. (FHTX) Snapshot price: $7.53

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found